Atlas Trials

Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure

Clinical trial NCT06196177 · UNKNOWN

Trial details

NCT number
NCT06196177
Sponsor
Qilu Hospital of Shandong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart FailureAortic Stenosis, Severe
Start date
2024-03-01
Primary completion
2025-01-01
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.